Literature DB >> 9577246

Estriol: safety and efficacy.

K A Head1.   

Abstract

While conventional hormone replacement therapy provides certain benefits, it is not without significant risks. Estriol has been found to provide some of the protection without the risks associated with stronger estrogens. Depending upon the situation, estriol may exert either agonistic or antagonistic effects on estrogen. Estriol appears to be effective at controlling symptoms of menopause, including hot flashes, insomnia, vaginal dryness, and frequent urinary tract infections. Results of research on its bone-density-maintaining effects have been contradictory, with the most promising results coming from Japanese studies. Estriol's effect on cardiac risk factors has also been somewhat equivocal; however, unlike conventional estrogen prescriptions, it does not seem to contribute to hypertension. Although estriol appears to be much safer than estrone or estradiol, its continuous use in high doses may have a stimulatory effect on both breast and endometrial tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577246

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  11 in total

1.  Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

Authors:  Noriko Itoh; Roy Kim; Mavis Peng; Emma DiFilippo; Hadley Johnsonbaugh; Allan MacKenzie-Graham; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

2.  Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.

Authors:  Tracey L Papenfuss; Nicole D Powell; Melanie A McClain; Ashley Bedarf; Amber Singh; Ingrid E Gienapp; Todd Shawler; Caroline C Whitacre
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

Review 3.  Bioidentical hormone therapy.

Authors:  Julia A Files; Marcia G Ko; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-04-29       Impact factor: 7.616

4.  Estrogen treatment in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  J Neurol Sci       Date:  2009-06-18       Impact factor: 3.181

Review 5.  Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.

Authors:  Cihat Unlü; Gilbert Donders
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

Review 6.  Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.

Authors:  Rhonda Voskuhl; Callene Momtazee
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Neuroendocrine immunoregulation in multiple sclerosis.

Authors:  Nathalie Deckx; Wai-Ping Lee; Zwi N Berneman; Nathalie Cools
Journal:  Clin Dev Immunol       Date:  2013-12-08

8.  Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.

Authors:  Gilbert Donders; Patrick Neven; Maximilian Moegele; Anneleen Lintermans; Gert Bellen; Valdas Prasauskas; Philipp Grob; Olaf Ortmann; Stefan Buchholz
Journal:  Breast Cancer Res Treat       Date:  2014-04-10       Impact factor: 4.872

9.  Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Authors:  Reagan L Ross; Michelle R Serock; Raouf A Khalil
Journal:  Curr Cardiol Rev       Date:  2008-11

10.  Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.

Authors:  U Jaisamrarn; S Triratanachat; S Chaikittisilpa; P Grob; V Prasauskas; N Taechakraichana
Journal:  Climacteric       Date:  2013-03-04       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.